74 related articles for article (PubMed ID: 12593716)
1. Monoclonal antibodies with thyroid stimulating activity, at last.
Costagliola S; Vassart G
Thyroid; 2002 Dec; 12(12):1039-41. PubMed ID: 12593716
[No Abstract] [Full Text] [Related]
2. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
Baker JR; Saunders NB; Kaulfersch W; Burman KD
J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
[TBL] [Abstract][Full Text] [Related]
3. Thyroid-stimulating antibodies of Graves' disease in thyroid cancer.
Röher HD; Goretzki PE; Frilling A
N Engl J Med; 1988 Dec; 319(25):1669-70. PubMed ID: 3200284
[No Abstract] [Full Text] [Related]
4. Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Kohn LD; Ekins RP; Marshall NJ
J Clin Endocrinol Metab; 1984 May; 58(5):909-14. PubMed ID: 6546765
[TBL] [Abstract][Full Text] [Related]
5. Thyroid-stimulating monoclonal antibodies.
Sanders J; Jeffreys J; Depraetere H; Richards T; Evans M; Kiddie A; Brereton K; Groenen M; Oda Y; Furmaniak J; Rees Smith B
Thyroid; 2002 Dec; 12(12):1043-50. PubMed ID: 12593717
[TBL] [Abstract][Full Text] [Related]
6. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity of thyroid disease. With emphasis on Graves' disease.
van Ouwerkerk BM; Krenning EP; Docter R; Benner R; Hennemann G
Neth J Med; 1985; 28(1):32-9. PubMed ID: 2858065
[No Abstract] [Full Text] [Related]
8. Postpartum recurrence of hyperthyroidism and changes of thyroid-stimulating immunoglobulins in Graves' disease.
Yabu Y; Amino N; Mori H; Miyai K; Tanizawa O; Takai SI; Kumahara Y; Matsuzuka F; Kuma K
J Clin Endocrinol Metab; 1980 Dec; 51(6):1454-8. PubMed ID: 6108332
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of immunological markers in Graves' disease.
Mann K; Saller B; Hörmann R
Exp Clin Endocrinol; 1991 May; 97(2-3):224-30. PubMed ID: 1680726
[No Abstract] [Full Text] [Related]
11. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
[No Abstract] [Full Text] [Related]
12. Autoantibodies to the TSH receptor.
Zakarija M; McKenzie JM
Exp Clin Endocrinol; 1991 May; 97(2-3):165-9. PubMed ID: 1680725
[No Abstract] [Full Text] [Related]
13. [Antigenic relation between thyroid peroxidase and the microsomal antigen implicated in auto-immune diseases of the thyroid].
Czarnocka B; Ruf J; Ferrand M; Carayon P
C R Acad Sci III; 1985; 300(15):577-80. PubMed ID: 2410085
[TBL] [Abstract][Full Text] [Related]
14. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
[No Abstract] [Full Text] [Related]
15. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
Hopf U; Fiek T; Grün R; Zuschneid W
J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
[TBL] [Abstract][Full Text] [Related]
16. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
17. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
18. Thyroid antibodies in Graves' disease. An immunofluorescence study.
Szabó J; Leövey A
Acta Med Hung; 1983; 40(2-3):91-7. PubMed ID: 6366729
[TBL] [Abstract][Full Text] [Related]
19. Letter: Nomenclature of thyroid-stimulating antibodies.
Adams DD; Dirmikis S; Doniach D; El Kabir DJ; Hall R; Ibbertson HK; Irvine WJ; Kendall-Taylor P; Manley SW; Mehdi SQ; Munro DS; Purves HD; Smith BR; Stewart RD
Lancet; 1975 May; 1(7917):1201. PubMed ID: 48829
[No Abstract] [Full Text] [Related]
20. Biological and immunological characterization of ophthalmopathic Ig in Graves' ophthalmopathy.
Kálmán K; Leövey A; Hauck M; Szabo J; Bako G
Radiobiol Radiother (Berl); 1987; 28(5):576-9. PubMed ID: 2894705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
